Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Harmon

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Prostate Cancer and Prostatic Diseases|February 11, 2022
Outcomes in men with metastatic castration-resistant prostate cancer who received sipuleucel-T and no immediate subsequent therapy: experience at Dana Farber and in the PROCEED RegistryXiao X Wei, Lucia Kwak, Anis Hamid, et al.
Exploratory Research in Clinical and Social Pharmacy|August 27, 2024
Abandonment of prescriptions in medically underserved areas: Primary medication non-adherence in community pharmacies in the delta region of the United StatesMinghui Li, Matthew Harmon, Mike Wasson, et al.
The Journal of Heredity|April 19, 2014
Mapping and Expression of Candidate Genes for Development Rate in Rainbow Trout (Oncorhynchus mykiss)Matthew C Hale, John A Colletti, Scott A Gahr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2023
Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE TrialsEmmanuel S Antonarakis, Sumit K Subudhi, Christopher M Pieczonka, et al.
OTO Open|August 19, 2024
Idiopathic Subglottic Stenosis in Non-Caucasian WomenAmber Suk, Salem Dehom, Nihal Punjabi, et al.
Prostate Cancer and Prostatic Diseases|March 1, 2020
Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registryOliver Sartor, Andrew J Armstrong, Chiledum Ahaghotu, et al.
The Lancet. Respiratory Medicine|January 13, 2018
Induced hypothermia in patients with septic shock and respiratory failure (CASS): a randomised, controlled, open-label trialTheis Skovsgaard Itenov, Maria Egede Johansen, Morten Bestle, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Prostate Cancer and Prostatic Diseases|February 11, 2022
Outcomes in men with metastatic castration-resistant prostate cancer who received sipuleucel-T and no immediate subsequent therapy: experience at Dana Farber and in the PROCEED RegistryXiao X Wei, Lucia Kwak, Anis Hamid, et al.
Exploratory Research in Clinical and Social Pharmacy|August 27, 2024
Abandonment of prescriptions in medically underserved areas: Primary medication non-adherence in community pharmacies in the delta region of the United StatesMinghui Li, Matthew Harmon, Mike Wasson, et al.
The Journal of Heredity|April 19, 2014
Mapping and Expression of Candidate Genes for Development Rate in Rainbow Trout (Oncorhynchus mykiss)Matthew C Hale, John A Colletti, Scott A Gahr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2023
Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE TrialsEmmanuel S Antonarakis, Sumit K Subudhi, Christopher M Pieczonka, et al.
OTO Open|August 19, 2024
Idiopathic Subglottic Stenosis in Non-Caucasian WomenAmber Suk, Salem Dehom, Nihal Punjabi, et al.
Prostate Cancer and Prostatic Diseases|March 1, 2020
Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registryOliver Sartor, Andrew J Armstrong, Chiledum Ahaghotu, et al.
The Lancet. Respiratory Medicine|January 13, 2018
Induced hypothermia in patients with septic shock and respiratory failure (CASS): a randomised, controlled, open-label trialTheis Skovsgaard Itenov, Maria Egede Johansen, Morten Bestle, et al.
Pageof 2